The global medical food brands market size is expected to reach USD 33.85 Billion in 2030 and register a revenue CAGR of 5.4% over the forecast period, according to latest report by Reports and Data. Rising demand for medical food brands, due to rapid increase in geriatric population suffering from chronic diseases, and increasing use of medical food brands to control and manage diabetic neuropathy are expected to drive market revenue growth during the forecast period. Increasing collaborations and frequent product launches by key players are also expected to drive revenue growth of the market. Manufacturers are collaborating to come up with better products to satisfy global demand with rising awareness about medical food brands. In addition, they are investing heavily in research & development to manufacture better products and holding frequent promotional campaigns, which is supporting global market revenue growth and is expected to continue to do so during the forecast period.

However, high costs and low availability of medical food brands in developing countries are expected to hamper market revenue growth. medical food brands are costly when compared to traditional food products. In addition, low investments in medical food brands in developing countries is leading to low production and less variation in products, resulting in low availability of medical food brands. This, in turn, is increasing prices of medical food brands and thus, hampering revenue growth of the market.

Get a sample of the report @

Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights in the Report

  • The powder segment is expected to account for largest revenue share during the forecast period. Increasing adoption of powdered medical food brands among geriatric and pediatric population and their ease of consumption are major factors driving revenue growth of this segment. In addition, large availability of powdered foods and the fact that powdered medical food brands can be administered through both oral and enteral routes to patients of all ages are expected to support revenue growth of this segment during the forecast period.
  • The diabetic neuropathy segment is expected to register the fastest CAGR during the forecast period, owing to rising cases of diabetes and increase in the number of patients that can develop neuropathy. In addition, various new initiatives to manage neuropathy through dietary measures is expected to drive revenue growth of this segment. Furthermore, 50% of adults suffering from diabetes are affected by peripheral neuropathy, and increasing incidence of this health condition is expected to support revenue growth of this segment during the forecast period.  
  • North America accounted for largest revenue share in the global medical food brands market in 2021 and is expected to lead in terms of revenue contribution to the global market during the forecast period as well. The US has contributed the most to North America market revenue, while Canada and Mexico have also contributed considerably and are expected to continue to do so in the near future. Increasing incidence of chronic diseases in geriatric population is a major factor driving revenue growth of the North America market.
  • In June 2018, VAYA Pharma, Inc. introduced Vayarin Plus, an extra-strength formula for the dietary management of overweight Attention Deficit Hyperactivity Disorder (ADHD) patients.

Top Players in the Global medical food brands Market:

Targeted Medical Pharma, Medtrition, Inc., Nestle, Abbott Laboratories, Danone, Fresenius Kabi, Primus Pharmaceuticals, Inc., Mead Johnson & Company, LLC, Victus, Inc., and Meiji Holdings Co.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @

medical food brands Market Segmentation:

Product Outlook (Revenue, USD Billion; 2019-2030)

  • Liquid
  • Powder
  • Pills
  • Others

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

  • Oral
  • Enteral

Application Outlook (Revenue, USD Billion; 2019-2030)

  • Chemotherapy-induced Diarrhea
  • Diabetic Neuropathy
  • Alzheimer’s Disease
  • Pathogen related infections
  • Others

Sales Channel Outlook (Revenue, USD Billion; 2019-2030)

  • Online Sales
  • Institutional Sales
  • Retail Sales

Global medical food brands Market Report: Regional Segmentation

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request customization of the report @

Read More Reports:

Pipette Tip Market:

Spinal Cord Stimulation Devices Market:

Sperm Analyzer Market:

Disposable Swabs Market:

Oral Thin Films Market:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.